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The purpose of this work was to evaluate the intrapatient tumor position reproduc-
ibility in a deep inspiration breath-hold (DIBH) technique based on two infrared 
optical tracking systems, ExacTrac and ELITETM, in stereotactic treatment of 
lung and liver lesions. After a feasibility study, the technique was applied to 15 
patients. Each patient, provided with a real-time visual feedback of external optical 
marker displacements, underwent a full DIBH, a free-breathing (FB), and three 
consecutive DIBH CT-scans centered on the lesion to evaluate the tumor position 
reproducibility. The mean reproducibility of tumor position during repeated DIBH 
was 0.5 ± 0.3 mm in laterolateral (LL), 1.0 ± 0.9 mm in anteroposterior (AP), and 
1.4 ± 0.9 mm in craniocaudal (CC) direction for lung lesions, and 1.0 ± 0.6 mm in 
LL, 1.1 ± 0.5 mm in AP, and 1.2 ± 0.4 mm in CC direction for liver lesions. Intra- 
and interbreath-hold reproducibility during treatment, as determined by optical 
markers displacements, was below 1 mm and 3 mm, respectively, in all directions 
for all patients. Optically-guided DIBH technique provides a simple noninvasive 
method to minimize breathing motion for collaborative patients. For each patient, 
it is important to ensure that the tumor position is reproducible with respect to the 
external markers configuration.
PACS numbers: 87.53.Ly, 87.55.km
Key words: deep inspiration breath-hold, extracranial stereotactic treatment, opto-
electronic system, organ motion
I. IntroDuctIon
Tumors in the thorax and upper abdomen are subject to respiratory-driven motion. In conven-
tional radiotherapy, large safety margins up to 2.0 cm are added to the clinical target volume 
(CTV) to account for breathing motion and setup errors.(1) Respiration motion also causes arti-
facts during image acquisition, such as warping of the target volume and erroneous positional 
and volumetric information.(2)
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There are three techniques, clinically implemented, able to reduce the effects of respiratory 
motion. The first is based on abdominal pressure obtained with a plastic plate, often applied 
to extracranial stereotactic treatments using a body frame.(3) The second technique involves 
the irradiation delivery at a predefined phase of the respiratory cycle, by gating the accelera-
tor while the patient is freely breathing. Methods for gating include monitoring motion of the 
abdominal wall, spirometer, laser sensor system, and marker tracking.(4-7) A disadvantage of 
gating is decreased delivery efficiency, with longer imaging and treatment times. The third 
technique requires the patient to perform specific maneuvers of respiration, either voluntary(8-10) 
or with the aid of devices.(11-15) Stock et al.(16) developed a noninvasive method based on the 
opto-electronic tracking of passive markers. The breath-hold technique can be performed 
either at end of expiration, more reproducible but less comfortable for the patient, or at end of 
inspiration.(17) Deep inspiration breath-hold has particular advantages in lung tumors, allowing 
a reduction of lung density with a decrease of normal tissue in the high-dose region. This has 
the potential for dose escalation for the same calculated lung morbidity, even without margin 
reduction. In order to avoid severe pulmonary toxicity, lung volume receiving more than 20 Gy 
should not exceed 20% of the total volume.(18) Barnes et al.(19) showed a 32.5% reduction of 
the lung volume receiving more than 20 Gy using a DIBH technique. Furthermore, the reduced 
target motion during DIBH may justify a smaller safety margin from CTV to planning target 
volume (PTV).(20)
Nevertheless, in some cases the distance of the PTV to the OARs may increase for other 
breathing phases and therefore warrant a different phase than DIBH.
In this work, we investigated the use of DIBH technique in stereotactic treatments of lung and 
liver lesions using two infrared optical tracking systems, ExacTrac (BrainLAB AG, Germany) 
and ELITE (BTS S.p.a., Milan, Italy), in the attempt to either increase the dose or reduce the 
safety margin. To guide the DIBH we used the ELITE system, which has already been used in 
our Institute to evaluate setup errors and their dosimetric consequences in breast treatments,(21,22) 
as well as in frameless body stereotactic treatments.(23,24)
We first performed a feasibility study on three voluntary subjects to evaluate the reproduc-
ibility of the technique, followed by an analysis on eight patients to correlate the patient surface 
and the tumor position reproducibility. Finally, the results of the first 15 patients treated with 
the DIBH protocol have been reported.
 
II. MAtErIALS AnD MEtHoDS
A.  Infra-red optical tracking
Both optical tracking systems, ExacTrac and ELITETM, use two infrared cameras, which 
are mounted in the ceiling of the linac vault, to track passive optical markers (radius: 5 mm) 
placed on selected skin landmarks. A calibration procedure is used in order to determine the 
position of any passive optical marker relative to the isocenter. Both systems were calibrated 
with respect to a common isocentric reference frame and they provided submillimetric accuracy 
in markers 3D localization.(25)
The optical markers were attached to the patient by using an adhesive backing before CT 
scanning, and their position was referenced with ink marking to aid reapplication for each 
treatment fraction. CT scan data were sent to the treatment planning system (TPS) (BrainScan, 
BrainLAB AG), where the isocenter was established relative to the stereotactic coordinate 
system defined by the optical markers configuration which was used for positioning. 
ExacTrac was the reference system to set up the patient in free breathing, providing the 
operator with the corrective translations and rotations. ELITE was the reference system for 
guiding the patient during the DIBH in both CT and treatment rooms. A specific software was 
implemented to provide the operators with the real-time 3D displacements of the optical  markers 
configuration with respect to the reference one. 
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B.  Feasibility study of the DIBH technique 
B.1 Volunteer study
In order to assess the reproducibility of the technique as a function of the specific feedback 
to the patient, a feasibility study was performed on three voluntary subjects. Five consecutive 
acquisitions of 3D marker positions were performed for each subject lying in supine position 
on the CT couch during a 15 sec DIBH with two feedback conditions: i) verbal instructions by 
an operator, based on real-time feedback of marker displacements; ii) direct visual feedback 
to the subject. 
B.2 CT patient study
A CT study was performed on eight patients. Only collaborative patients with a Karnofsky index 
> 70 were enrolled in the feasibility study, as well as in the treatment protocol. The patient 
characteristics are shown in Table 1 (patients #1-7, #16). Patients were immobilized supine in 
an individualized vacuum cushion with an arm holder. 
Real-time visual feedback, prompting instantaneous (at ~ 30 Hz video refresh rate) infor-
mation of the inspiration level, was obtained through an eyewear viewer (SV-6 PC Viewer; 
MicroOptical Co., Westwood, MA) (Fig. 1) connected to the ELITE data logger, showing the 
optical marker displacements in LL, CC, and AP directions, with respect to a reference configu-
ration, as bars. The patient was first instructed to have a reproducible breathing pattern and then 
was trained to achieve a reproducible DIBH level, keeping the AP bars below a 3 mm threshold. 
When the bars exceeded the threshold, their color changed from green to red. A configuration 
of seven optical markers was used, four positioned in stable points to assure a correct setup in 
FB and three on upper abdomen in points representative of the DIBH maneuver. Acquisition 
of the reference 3D marker positions was performed at a comfortable level of DIBH and the 
duration of the breath-hold was established.
Each patient underwent a FB CT scan and three consecutive DIBH CT series spanning the 
region across the tumor (usually 20 slices), acquired with 3 mm thick slices. Each DIBH CT 
series was acquired during a single breath-hold of about 16 sec (one slice acquired in 0.8 sec). 
Table 1. Characteristics of the patients enrolled in the feasibility study and in the treatment protocol.
       Thoracic/ Treatment/
       Liver  Feasibility
 No. Age Sex Site Subsite Comorbidities Surgery Study
 1 44 F Left lung Upper lobe Hypertension No Feasibility study
 2 44 F Right lung Lower lobe Hypertension No Feasibility study
 3 62 F Mediastinum Station R4 Heart disease Yes Feasibility study
 4 48 M Left lung Lower lobe - Yes Feasibility study
 5 50 F Left lung Upper lobe - No Feasibility study
 6 63 M Mediastinum Station 5 COPD No Feasibility study
 7 59 M Left lung Lower lobe Heart disease No Feasibility study
 8 61 M Right lung Lower lobe - Yes Treatment
 9 53 F Right lung Medium lobe - No Treatment
 10 66 M Right lung Medium lobe Left Pneumothorax No Treatment
 11 53 F Left lung Lingula - No Treatment
 12 62 M Right lung Lower lobe - No Treatment
 13 60 M Right lung Lower lobe - Yes Treatment
 14 54 M Right lung Upper lobe COPD Yes Treatment
 15 69 F Left lung Upper lobe Left Diaphragm Relaxation No Treatment
 16 43 F Liver Hilar node - Yes Feasibility study
 17 58 M Liver V segment - No Treatment
 18 59 M Liver VII segment - Yes Treatment
 19 61 F Liver IV segment - No Treatment
 20 59 M Liver VII segment - Yes Treatment
 21 68 F Liver VII segment - Yes Treatment
 22 56 F Liver VII segment Hypertension Yes Treatment
 23 54 F Liver IV segment - No Treatment
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Moreover, shallow inspiration and expiration breath-hold CT scans centered on the lesion to 
assess the extent of tumor motion under FB conditions were also acquired.
All CT scans were registered on the FB CT scan using a pair objects technique provided by 
the TPS; three landmarks on the patient tray and one vertebral body were used. The accuracy 
of the image fusion, determined by evaluating the contours of fixed anatomical structures, 
was below 1 mm. The GTV was contoured on each slice by a single radiation oncologist. We 
measured an intra-observer variability of 1.5 mm, evaluated by repeating three times the tumor 
delineation of two patients and considering the shift in the tumor center of mass.
In Fig. 2, three DIBH CT series registered on the FB scan are shown for a lung patient 
enrolled in the feasibility study. Artifacts in tumor volume and position in the FB CT scan are 
visible in the sagittal and coronal CT reconstructions.
Fig. 1. Patient with passive markers and eyewear viewer (a) showing in real-time marker displacements in LL, CC, and 
AP directions (with respect to a reference configuration (b)).
(a)
(b)
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We investigated the correlation between the GTV and the optical markers displacement 
from FB to DIBH, in terms of entity and reproducibility. Tumor displacement was assessed by 
evaluating the displacement of the GTV center of mass along the LL, CC, and AP directions 
between FB and DIBH. As a surrogate of surface motion, we considered the mean value of the 
positions of abdominal optical markers used to guide the DIBH maneuver. The reproducibility 
of tumor displacement was evaluated considering the SD of the position of the GTV center of 
mass between consecutive DIBH CT scans, while the reproducibility of marker displacements 
was evaluated considering the mean SD of the coordinates of abdominal markers digitized on 
the TPS. 
c.  clinical implementation of DIBH protocol
C.1 CT simulation
Each patient underwent a full DIBH CT scan, split into segments lasting about 15 sec each, 
including all involved organs for the DVH analysis and three consecutive DIBH CT scans, 
centered on the lesion, to evaluate tumor position reproducibility. A full FB scan for setup and 
shallow inspiration and expiration breath-hold scans centered on the lesion to assess the extent 
of tumor motion were also acquired. The same procedure as described in the feasibility study 
(Materials and Methods Section B above) was followed.
A verification CT in DIBH centered on the lesion was acquired before each treatment  section, 
since a cone beam CT was not available on the linac. 
So far, 15 patients have been treated with the DIBH protocol and their characteristics are 
shown in Table 1 (Patients #8-15, #17-23).
C.2 Treatment planning
The treatment technique consisted of a single or multiple noncoplanar arcs of 6 MV photon 
beams conformed to the PTV by means of a dynamic micromultileaf collimator (m3, BrainLAB 
AG). For metastases, the CTV was equal to GTV, while for primary tumors the CTV was 
defined as the GTV plus 5 mm margin. The PTV was defined by adding to the CTV drawn on 
the DIBH CT scan the same margins of the FB plan. Patient-specific margins of 5–8 mm in 
LL and 8–18 mm in both AP and CC were used, taking into account organ motion and 3 mm 
isotropic setup margin.(23) An additional margin of 3 mm was added to the PTV to account 
for beam penumbra. Moreover, an extra 2 mm margin was used to compensate the reduced 
accuracy of our dose calculation algorithm, not accounting for lateral electronic disequilibrium 
in the lung. 
Fig. 2. Reproducibility of tumor position during repeated DIBH CT scans fused on the FB CT scan (shown in pink).
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We compared the CTV to PTV margins, derived from the FB method, with the uncertainty-
based margins calculated taking into account the following uncertainties, combined in quadrature, 
involved in the process: patient specific tumor position reproducibility in DIBH (1.5 SD), setup 
margin, intra-observer variability in tumor delineation, and uncertainty in image fusion. 
Treatment doses, prescribed at the isocenter, ranged between 30 Gy delivered in 2 fractions 
and 54 Gy delivered in 3 fractions with 48 hours interval. 
C.3 Treatment delivery
Patients were treated on a Varian Clinac 600 C/D (Varian Medical Systems, Palo Alto, CA) 
equipped with an electronic portal imaging device. Patient setup was performed according to 
ExacTrac. Following initial manual alignment with skin marks and lasers, the position of the 
couch was automatically adjusted on the basis of optical marker localization in order to achieve 
a treatment position where the markers matched the reference configuration defined on the treat-
ment planning CT, especially the stable ones. Final patient setup verification was performed by 
means of a couple of orthogonal electronic portal images acquired in FB and compared with the 
corresponding DRRs. Bony structures stable during respiration, such as vertebral spine, were 
used to verify the correct patient position in FB as determined by ExacTrac. Each irradiation 
was split in 12–15 consecutive breath-holds lasting about 15–20 sec each, using high-dose rate 
(500 MU/min). During each breath-hold, the beam was switched on manually when the patient 
reached the correct level given by the ELITE system and switched off before the operator told 
the patient to freely breath. 
We analyzed the intra- and inter-DIBH reproducibility, considering the mean SD and the 
root mean square error (RMS) of marker displacements, respectively.
 
III. rESuLtS 
A.  Feasibility study of the reproducibility of DIBH technique
Real-time visual feedback of marker displacements to the voluntary subjects led to a significantly 
higher repeatability of surface localization during DIBH, with overall mean 3D displacement 
of 2.2 ± 0.8 mm, compared to a mean value of 3.2 ± 1.1 obtained with verbal instructions given 
by an operator (p = 0.0003).
B.  ctV to PtV margins
In Table 2 are shown for all patients the SD of the GTV positions in repeated DIBH CT scans and 
the uncertainty-based CTV to PTV margins calculated combining in quadrature the patient-specific 
tumor position reproducibility in DIBH (1.5 SD), the setup margin (3 mm), the intra-observer 
variability in tumor delineation (1.5 mm), and the uncertainty in image fusion (0.5 mm).
The mean difference between uncertainty-based margins in DIBH and the standard ones 
determined with the FB method (used for the treatment) was -1.9 ± 0.5 mm in LL, -5.0 ± 1.5 mm 
in AP, and -6.0 ± 1.8 mm in CC directions. 
Despite reduced respiratory motion, CTV to PTV margins were not reduced so far, first 
because we want to acquire more confidence with the technique. The second reason concerns 
lung treatments and it is related to the dose calculation algorithm implemented in our TPS (see 
Discussion section below).
All lung patients exhibited a significant decrease in the PTV for the DIBH plan compared to 
the one obtained in the FB plan, due to target immobilization (p = 0.003). We observed an overall 
mean variation of -13.0% ± 9.3% with a maximum value of -30.9% ± 3.1%. For patients with 
liver lesions, although the tumor was visible in all CT scans allowing us to evaluate the center 
of mass reproducibility during repeated DIBH CT scans, we did not compare the volumes, since 
we found some differences depending on the time interval from the contrast medium injection 
and the CT scan acquisition.
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c. Displacement of target and passive markers between FB and DIBH
Entity and reproducibility of tumor and markers displacement from FB to DIBH for all patients 
are shown in Table 3.
Figures 3 and 4 show the tumor and markers displacement from FB to DIBH along the three 
directions for patients with lung and liver diseases, respectively. For lung tumors situated in the 
lower lobes, the largest displacement was observed in the caudal direction with a maximum 
value up to 40 mm, while tumors located in the upper lobes displayed maximal displacement 
along the AP direction, with a maximum value of 33 mm. Most tumors showed minimal move-
ment along the LL direction, but for three patients it was larger than 5 mm. 
We did not find any correlation (Pearson correlation coefficient) between the marker and 
the tumor displacement in any directions among the patients. 
All patients with liver lesions, except one, exhibited a caudal displacement of the target, 
caused by the increased lung volume pushing down the liver. The only patient showing target 
displacement in the opposite direction had a lesion very close to the diaphragm pushed up dur-
ing DIBH. Relevant displacements were also observed in AP direction. One lesion, located on 
the diaphragm, exhibited a displacement of 17.7 mm in LL direction.
A correlation between tumor and marker displacement in CC direction (regression line r2 = 
0.7178, p = 0.0021) has been found for liver lesions.
We observed a high variability of tumor displacement between FB and DIBH among the 
patients, which may be caused by different respiration modality, thoracic or abdominal, as well 
as position of the lesion.
Data from the verification CT acquired before each treatment section confirmed the reproduc-
ibility of tumor position during DIBH assessed during the simulation CT for all patients.
Table 2. Reproducibility of the GTV positions in repeated DIBH CT scans and the uncertainty-based margins calcu-
lated on an individual basis.
 SD of GTV Positions in Consecutive DIBHs CTV-PTV Margins
 Patient LL AP CC LL AP CC
 N° (mm) (mm) (mm) (mm) (mm) (mm)
 1 0.9 0.5 1.6 3.6 3.5 4.2
 2 1.0 1.4 2.9 3.7 4.0 5.5
 3 0.3 0.8 0.4 3.4 3.6 3.4
 4 0.2 1.7 1.8 3.4 4.2 4.3
 5 0.4 0.1 1.5 3.4 3.4 4.1
 6 0.4 1.7 2.1 3.4 4.2 4.6
 7 0.9 0.9 0.8 3.7 3.7 3.6
 8 0.7 0.5 1.4 3.6 3.5 4.0
 9 1.2 3.6 3.3 3.8 6.4 6.0
 10 0.5 0.6 0.5 3.5 3.5 3.5
 11 0.1 0.1 1.8 3.4 3.4 4.3
 12 0.2 1.1 1.5 3.4 3.8 4.1
 13 0.4 0.2 0.5 3.4 3.4 3.5
 14 0.2 0.5 0.9 3.4 3.5 3.7
 15 0.4 1.0 0.4 3.4 3.7 3.4
 16 0.6 0.5 0.4 3.5 3.5 3.4
 17 0.9 0.9 1.2 3.6 3.7 3.8
 18 1.1 1.6 1.3 3.8 4.1 3.9
 19 0.4 0.8 1.3 3.4 3.6 3.9
 20 0.0 1.0 1.1 3.4 3.7 3.8
 21 1.4 0.5 1.6 4.0 3.5 4.2
 22 1.9 1.9 1.7 4.4 4.4 4.2
 23 1.6 1.5 1.0 4.2 4.1 3.7
 mean 0.7 1.0 1.3 3.6 3.8 4.1
 SD 0.5 0.8 0.8 0.3 0.6 0.6
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Table 3. Entity and reproducibility of tumor and markers displacement from FB to DIBH CT scans for all patients 
enrolled in the feasibility study and in the treatment protocol.
 LL  AP  CC
    Mean + SD Range Mean + SD Range Mean + SD Range
    (mm) (mm) (mm) (mm) (mm) (mm)
  Tumor Displacement 1.4±5.0 -6.6/12.9 16.8±8.1 4.5/33.0 -12.7±11.5 -39.6/3.9
 Lung  Reproduc. 0.5±0.3 0.1/1.2 1.0±0.9 0.1/3.6 1.4±0.9 0.4/3.3   Markers Displacement 0.3±2.2 -4.7/5.2 12.7±5.8 4.4/24.8 10.1±4.2 3.0/21.0   Reproduc. 0.6±0.5 0.3/1.5 1.1±0.8 0.3/3.0 1.6±0.7 0.8/2.7
  Tumor Displacement 1.4±7.2 -6.2/17.7 16.0±9.1 7.7/36.7 -19.9±21.4 -43.9/20.5
Liver  Reproduc. 1.0±0.6 0.0/1.9 1.1±0.5 0.5/1.9 1.2±0.4 0.4/1.7   Markers Displacement 1.0±1.5 -1.4/2.8 15.8±7.1 6.1/25.0 10.6±8.0 -3.0/23.0   Reproduc. 0.7±0.4 0.3/1.1 1.6±1.2 0.6/3.6 1.6±0.4 1.0/2.0
 
Fig. 3. Displacement of GTV and passive markers between FB and DIBH in all directions for lung lesions. 
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D.  Patient performance during the DIBH treatment
The mean number of breath-holds per fraction was 10.8 ± 2.1 (range: 6.0 to 16.0). The mean 
number of frames acquired during a single breath-hold was 288 ± 97, with mean breath-hold 
duration of about 15 sec and a sample rate of 20 Hz. Intra- and interbreath-hold reproducibility, 
as determined by marker displacements, for all treated patients is shown in Table 4.
We found larger RMS errors in LL and CC directions due to the fact that, although the patients 
could have real-time feedback of markers displacements along the three directions, they were 
told to reproduce as better as possible their reference positions along the AP direction.
 
Fig. 4. Displacement of GTV and passive markers between FB and DIBH in all directions for liver lesions. 
23  Garibaldi et al.: optically-guided DIBH stereotactic treatments 23
Journal of Applied clinical Medical Physics, Vol. 14, no. 4, 2013
IV. DIScuSSIon
A.   Feasibility study on the reproducibility of DIBH technique
Preliminary study showed that self-visual feedback increased the reproducibility of the patient 
surface. Our results are in agreement with other studies reported in the literature.(26) Some authors 
found a reproducibility of tumor position under patient self breath-hold without any respiratory 
monitoring device, with a difference of tumor position less than 3 mm in all directions.(10) 
B.  ctV to PtV margins
The PTV was smaller in DIBH compared to FB, even using the same margins derived from 
the FB plan, due to the fact that artifacts in shape and location of the lesion caused by the CT 
acquisition were minimized. Since the tumor is immobilized during DIBH, it might be pos-
sible to reduce the internal margin, taking into account only the residual tumor motion during 
breath-hold. Nevertheless, a margin reduction should be considered carefully if a pencil beam 
algorithm is used for dose calculation, as in our TPS. Since DIBH reduces lung density, the effect 
of a broadened penumbra at field edges due to electronic disequilibrium will be increased and 
may cause under dosage of targets, as pointed out by Fogliata et al.(27) Hanley et al.(20) showed 
that for 6 MV photon beams the penumbra broadening should have little clinical significance 
for DIBH treatments. Yorke et al.(28) found, using Monte Carlo, that lateral disequilibrium 
caused more decreased target coverage for DIBH than for FB. However, if DIBH enables 
higher prescription doses exceeding 10%, despite lateral disequilibrium, higher doses would 
be delivered to target volume.
We have planned to change our dose calculation algorithm with a more accurate one. In 
the meantime, the implementation of the DIBH technique allowed us to escalate the dose for 
selected patients. Two patients with a primary lung tumor received a treatment dose of 54 Gy 
in 3 fractions, while our standard protocol was 45 Gy in 3 fractions.
c.  Displacement of target and passive markers between FB and DIBH
The tumor displacement between FB and DIBH varied significantly among patients. We could 
not find any correlation between the movement of the markers used to guide the DIBH and 
tumor displacements for patients with lung lesions, while a weak linear regression was found 
in CC direction for patients with liver metastases. Nevertheless, this is not an important issue 
once the tumor position is reproducible with regard of the external markers position.
For each patient it is important to ensure that the tumor position is reproducible with respect 
to the external markers configuration by acquiring repeated DIBH CT scans during simulation. 
The availably of a cone-beam CT (CBCT) on the linac would allow one to acquire a DIBH-
gated CBCT in order to verify the tumor reproducibly just before the treatment. 
Our results are in agreement with those obtained by other investigators.(29,20) 
D.  Patient performance during the DIBH treatment
Only patients who could achieve sufficient reproducibility of DIBH after the training were 
included in the treatment protocol. All patients were able to complete the stereotactic treatment, 
some of them exhibiting fatigue at the end of the fraction. 
Table 4. Intra- and interbreath-hold reproducibility of marker displacements for all treated patients. 
 LL  AP  CC 
  Mean + SD Max Mean + SD Max Mean + SD Max
 Reproducibility (mm) (mm) (mm) (mm) (mm) (mm)
 Intra - DIBH 0.5±0.5 1.6 0.6±0.5 1.7 0.7±0.7 2.0
 Inter - DIBH 2.2±0.9 3.9 1.6±0.4 2.3 2.3±0.7 3.7
24  Garibaldi et al.: optically-guided DIBH stereotactic treatments 24
Journal of Applied clinical Medical Physics, Vol. 14, no. 4, 2013
Berson et al.(30) found a reduction of treatment time by a factor of 2 using breath-hold 
compared to gating. This is particularly important for hypofractionated stereotactic treatments, 
where high doses per fraction are delivered.
 
V. concLuSIonS
The DIBH technique, supported by an opto-electronic system, provides a simple and noninvasive 
method to minimize breathing motion for collaborative patients. A visual feedback provided to 
the patient led to a higher reproducibility of the technique. We strongly recommend an accurate 
CT study for each patient to evaluate the reproducibility of tumor position during the DIBH 
maneuver with respect to the external markers configuration. 
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